Whitesell et al., 2019 - Google Patents

Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus

Whitesell et al., 2019

View HTML @Full View
Document ID
14267612151764709056
Author
Whitesell L
Robbins N
Huang D
McLellan C
Shekhar-Guturja T
LeBlanc E
Nation C
Hui R
Hutchinson A
Collins C
Chatterjee S
Trilles R
Xie J
Krysan D
Lindquist S
Porco Jr J
Tatu U
Brown L
Pizarro J
Cowen L
Publication year
Publication venue
Nature communications

External Links

Snippet

New strategies are needed to counter the escalating threat posed by drug-resistant fungi. The molecular chaperone Hsp90 affords a promising target because it supports survival, virulence and drug-resistance across diverse pathogens. Inhibitors of human Hsp90 under …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds

Similar Documents

Publication Publication Date Title
Whitesell et al. Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Glomb et al. Antimicrobial activity of 1, 3, 4-oxadiazole derivatives
Ferraro et al. Allosteric modulators of HSP90 and HSP70: dynamics meets function through structure-based drug design
Ward et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
Schulze-Gahmen et al. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat
Cerchietti et al. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo
Dhawan et al. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling
Casiraghi et al. Targeting bacterial cell division: A binding site-centered approach to the most promising inhibitors of the essential protein FtsZ
Taldone et al. Selective targeting of the stress chaperome as a therapeutic strategy
Mani et al. PXR antagonists and implication in drug metabolism
Fujita et al. Structural flexibility of an inhibitor overcomes drug resistance mutations in Staphylococcus aureus FtsZ
Xie et al. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Melo et al. Structural insights into the activation mechanism of dynamin-like EHD ATPases
Chan et al. Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
Pietrobono et al. Targeting the oncoprotein smoothened by small molecules: focus on novel acylguanidine derivatives as potent smoothened inhibitors
Hauseman et al. Structure of the MRAS–SHOC2–PP1C phosphatase complex
Ramos Rego et al. TRAP1 in oxidative stress and neurodegeneration
Chen et al. Repurposing drugs to target the malaria parasite unfolding protein response
Rao et al. Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections
Kumar et al. Structural basis of inhibition of a transporter from Staphylococcus aureus, NorC, through a single-domain camelid antibody
Pellegrino et al. Understanding the role of intermolecular interactions between lissoclimides and the eukaryotic ribosome
Nardone et al. Structural basis of inhibition of the pioneer transcription factor NF-Y by suramin
Wang et al. Bromodomain-containing protein BRD4 is hyperphosphorylated in mitosis
Liu et al. A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy
Guberovic et al. Evolution of a histone variant involved in compartmental regulation of NAD metabolism